These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 26397178

  • 1. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 2. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Dec; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 3. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L, Frech-Tamas F, Marrett E, Baser O.
    Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
    [Abstract] [Full Text] [Related]

  • 4. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J, Ahn KT, Cho BR, Lee SY, Kim BJ, Kim DK, Park JI, Lee WS.
    Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
    [Abstract] [Full Text] [Related]

  • 5. A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination.
    Masi S, Kobalava Z, Veronesi C, Giacomini E, Degli Esposti L, Tsioufis K.
    Adv Ther; 2024 Jan; 41(1):182-197. PubMed ID: 37864626
    [Abstract] [Full Text] [Related]

  • 6. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G, Noetel A, Randerath O.
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
    [Abstract] [Full Text] [Related]

  • 7. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI.
    Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
    [Abstract] [Full Text] [Related]

  • 8. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
    Sison J, Assaad-Khalil SH, Najem R, Kitchlew AR, Cho B, Ueng KC, Shete A, Knap D.
    Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
    [Abstract] [Full Text] [Related]

  • 9. Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.
    Kawalec P, Holko P, Stawowczyk E, Borowiec Ł, Filipiak KJ.
    Kardiol Pol; 2015 Oct; 73(9):768-80. PubMed ID: 25987296
    [Abstract] [Full Text] [Related]

  • 10. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA, Hilleman DE.
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [Abstract] [Full Text] [Related]

  • 11. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations.
    Brixner DI, Jackson KC, Sheng X, Nelson RE, Keskinaslan A.
    Curr Med Res Opin; 2008 Sep; 24(9):2597-607. PubMed ID: 18812017
    [Abstract] [Full Text] [Related]

  • 12. A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    Snyman JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, Konradi AO, Perrone V, Borghi C.
    J Hypertens; 2024 Jan 01; 42(1):136-142. PubMed ID: 37728093
    [Abstract] [Full Text] [Related]

  • 13. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.
    Vasc Health Risk Manag; 2015 Jan 01; 11():71-8. PubMed ID: 25653536
    [Abstract] [Full Text] [Related]

  • 14. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W, Moin N, Iktidar S, Sakrani J, Abid R, Afzal J, Maheshwary N, Kumar K, Siddiqi A, Qadir M.
    Ther Adv Cardiovasc Dis; 2014 Apr 01; 8(2):45-55. PubMed ID: 24562476
    [Abstract] [Full Text] [Related]

  • 15. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
    Sicras Mainar A, Galera Llorca J, Muñoz Ortí G, Navarro Artieda R.
    Med Clin (Barc); 2011 Feb 26; 136(5):183-91. PubMed ID: 21106209
    [Abstract] [Full Text] [Related]

  • 16. [Medication adherence with the fixed combination of ramipril and amlodipine].
    Simonyi G, Ferenci T.
    Orv Hetil; 2014 Nov 23; 155(47):1882-8. PubMed ID: 25403283
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 23; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 18. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 23; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 19. China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III).
    Huo Y, Gu Y, Ma G, Guo J, Xiong L, Luo Z, Xie J, Li W, Zhao J, Yan X, Liu W, Xu Y, Bao X, Zhao L, Yang M, Wang B, Iii Study Group TCS.
    Curr Med Res Opin; 2019 Aug 23; 35(8):1441-1449. PubMed ID: 30880492
    [Abstract] [Full Text] [Related]

  • 20. Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
    Schmieder RE, Wassmann S, Predel HG, Weisser B, Blettenberg J, Gillessen A, Randerath O, Mevius A, Wilke T, Böhm M.
    Hypertension; 2023 May 23; 80(5):1127-1135. PubMed ID: 36987918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.